Richard Scott Huennekens's most recent trade in Envista Holdings Corp was a trade of 14,370 Common Stock done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Envista Holdings Corp | Richard Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 14,370 | 69,520 (0%) | 0% | 0 | Common Stock | |
| NeuroPace Inc | Richard Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 8,745 | 8,745 | - | - | Stock Option (right to buy) | |
| QuidelOrtho Corporation | Richard Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 6,829 | 6,829 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Richard Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 2,523 | 2,523 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Richard Scott Huennekens | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 2,523 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| NeuroPace Inc | Richard Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 15,507 | 15,507 | - | - | Stock Option (Right to Buy) |